CMPS

COMPASS Pathways plc
—

Company Information

Company Name
COMPASS Pathways plc
CIK
CIK0001816590
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
CMPS: Nasdaq
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
CMPS

SEC filing data through

Insider Sentiment

Last purchase
—
Last sale
2024-10-24
Shares purchased (TTM)
0
Shares sold (TTM)
4,606,447
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
90,098,797
Shares outstanding
135,039,810
Ownership
66.72%
+17.40% Y/Y

Earnings Market Reaction

Filing date
2026-08-05
Price on filing date
—
1-month reaction
1.10%
3-month reaction
…
Drift continued6/11 (55%)
Faded / reversed5/11 (45%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value433466150186222260165207229263220248
Restricted Cash And Cash Equivalents At Carrying Value000000000000
Prepaid Taxes---------110
Prepaid Expense And Other Assets Current--42---36-----
Other Prepaid Expense Current4244-565445362636314136
Assets Current476511191242276305201234265296261285
Equity Securities Without Readily Determinable Fair Value Amount-----------0
Assets Noncurrent
Operating Lease Right Of Use Asset433441233444
Deferred Income Tax Assets Net544544444433
Other Assets Noncurrent201412598776676
Assets505532210256294319214247279309276299
Liabilities And Stockholders Equity
Property Plant And Equipment Net-----------0
Liabilities Current
Accounts Payable Current12111551191288964
Accounts Payable And Other Accrued Liabilities Current16991210111414118119
Debt Current-------2----
Long Term Debt Current001813896---0-
Operating Lease Liability Current222221222222
Liabilities Current3671542481973130342622192015
Long Term Debt--------29292928
Liabilities Noncurrent
Long Term Debt Noncurrent5150141923222528--29-
Operating Lease Liability Noncurrent211220001122
Liabilities420205263218131124595452505046
Stockholders Equity
Common Stock Value11111111111-
Additional Paid In Capital1,0831,071784781767763705700695690622617
Accumulated Other Comprehensive Income Loss Net Of Tax-15-15-15-15-15-16-16-17-17-17-17-17
Retained Earnings Accumulated Deficit-985-731-823-729-591-553-535-491-453-415-380-347
Stockholders Equity85327-5338163195155193226259226253
Liabilities And Stockholders Equity505532210256294319214247279309276299
Ordinary Shares----94-9393-006800
Deferred Shares----------00
Common Stock Par Or Stated Value Per Share0.010.010.01---0.010.010.010.010.01-
Common Stock Shares Authorized136135969694936968686862-
Common Stock Shares Issued136135969694936968686862-
Shares Outstanding136135969694936968686862-

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

COMPASS Pathways plc (CMPS) — SEC Financial Statements & Analysis

COMPASS Pathways plc (CMPS) is a pharmaceutical preparations company, incorporated in X0. COMPASS Pathways plc trades on Nasdaq as: CMPS. COMPASS Pathways plc (CMPS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, COMPASS Pathways plc carries a market cap of $1.91B, a P/E ratio of -4.85x, a P/B ratio of 22.60x, an enterprise value of $1.53B, and an EV/EBITDA multiple of -8.41x. On profitability, it posts a Return on Equity (ROE) of -319.07%, a Return on Assets (ROA) of -98.78%, and a Return on Invested Capital (ROIC) of -662.33%. Per share, it reports EPS of $-2.92, diluted EPS of $-2.92, free cash flow per share of $-1.19, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 185.43% year-over-year and EPS growth of 97.30% year-over-year. On the balance sheet, it maintains a current ratio of 1.30x, a quick ratio of 1.30x, working capital of $108.39M, a debt-to-equity ratio of 4.97x, a debt ratio of 0.83, an interest coverage ratio of -35.02x, free cash flow of $-161.14M (TTM), and net debt of $-382.99M. Figures sourced from SEC EDGAR.

Market Cap
$1.91B
P/E TTM
-4.85x
EPS TTM
$-2.92
P/B TTM
22.60x
ROE TTM
-319.07%
ROA TTM
-98.78%
Debt To Equity
4.97x
Free Cash Flow TTM
$-161.14M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is COMPASS Pathways plc in?

COMPASS Pathways plc (CMPS) operates in the Pharmaceutical Preparations industry.

What exchange does CMPS trade on?

COMPASS Pathways plc (CMPS) trades on the Nasdaq.

Where is COMPASS Pathways plc incorporated?

COMPASS Pathways plc is incorporated in United Kingdom.

When was COMPASS Pathways plc (CMPS)'s most recent SEC filing?

COMPASS Pathways plc (CMPS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.

What is CMPS's market cap?

COMPASS Pathways plc (CMPS) has a market capitalization of $1.91B as of 2026-06-30.

What is CMPS's EPS (earnings per share)?

COMPASS Pathways plc (CMPS)'s trailing twelve month EPS is $-2.92 as of 2026-06-30.

What is CMPS's ROE (return on equity)?

COMPASS Pathways plc (CMPS)'s trailing twelve month Return on Equity (ROE) is -319.07% as of 2026-06-30.

What is CMPS's ROA (return on assets)?

COMPASS Pathways plc (CMPS)'s trailing twelve month Return on Assets (ROA) is -98.78% as of 2026-06-30.

What is CMPS's ROIC (return on invested capital)?

COMPASS Pathways plc (CMPS)'s trailing twelve month Return on Invested Capital (ROIC) is -662.33% as of 2024-12-31.

What is CMPS's EV/EBITDA?

COMPASS Pathways plc (CMPS)'s trailing twelve month EV/EBITDA is -8.41x as of 2026-06-30.

Wall Street's data.
Main Street's price.